Polyglyconate Unidirectional Barbed Suture for Posterior Reconstruction and Anastomosis During Robot-assisted Prostatectomy: Effect on Procedure Time, Efficacy, and Minimum 6-month Follow-up
Overview
Urology
Affiliations
Background And Purpose: With widespread implementation of posterior rhabdosphincter reconstruction (RSR) followed by urethrovesical anastomosis (UVA), reconstruction has become a significant portion of robot-assisted laparoscopic prostatectomy (RALP). Successful anastomosis can be measured by time for reconstruction and the absence of urinary leak. We prospectively evaluated the experience of a single surgeon (KKB) in using the V-Loc™ wound closure device for the posterior RSR and UVA, and compared it with a standard reconstruction and anastomosis.
Patients And Methods: A total of 84 patients divided into two groups underwent RALP, undergoing RSR and UVA using a Van Velthoven technique with the V-Loc or with a standard 3-0 monofilament suture. The primary end point was the time to complete RSR, UVA, and the total reconstruction. As a secondary end point, the clinical evidence of an anastomotic leak was also documented.
Results: The mean RSR, UVA, and total times were 9, 18, and 27 minutes for the control group, and 6, 12 and 18 minutes for the V-Loc group, respectively. The time differences between the two groups for RSR, UVA, and total time were 3 minutes (P<0.01), 6 minutes (P<0.01), and 9 minutes (P<0.001), respectively. There was no clinical evidence of anastomotic leak in either group. Continence recovery was equivalent between the groups at 6 weeks and 6 months. At a 9-month follow-up, no patients in either group had a clinical UVA stricture necessitating intervention.
Conclusions: The V-Loc suture is associated with a significantly shorter time for the RSR and UVA compared with the traditional suture and is not associated with a higher incidence of clinical urinary leak; however, a larger randomized study with long-term follow-up is necessary to confirm these results.
Rajih E, Meskawi M, Alenizi A, Zorn K, Alnazari M, Borhan W Can Urol Assoc J. 2019; 14(3):E74-E79.
PMID: 31599716 PMC: 7053370. DOI: 10.5489/cuaj.5959.
Pennestri F, Gallucci P, Prioli F, Giustacchini P, Ciccoritti L, Sessa L Updates Surg. 2018; 71(1):113-120.
PMID: 30191533 DOI: 10.1007/s13304-018-0589-2.
Dal Moro F, Beltrami P, Zattoni F Cent European J Urol. 2018; 71(1):21-25.
PMID: 29732202 PMC: 5926642. DOI: 10.5173/ceju.2018.1587.
Albisinni S, Aoun F, Peltier A, van Velthoven R Prostate Cancer. 2016; 2016:1481727.
PMID: 27340567 PMC: 4906212. DOI: 10.1155/2016/1481727.
Li H, Liu C, Zhang H, Xu W, Liu J, Chen Y PLoS One. 2015; 10(7):e0131167.
PMID: 26135310 PMC: 4489906. DOI: 10.1371/journal.pone.0131167.